Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2008
09/23/2008CA2371393C Use of bismuth subgallate in inhibition of production of nitric oxide synthase
09/23/2008CA2362253C Avermectin derivatives
09/23/2008CA2354852C 4,5-azolo-oxindoles
09/23/2008CA2354039C Pharmaceutical formulations in hydroxypropylmethylcellulose capsules
09/23/2008CA2352915C Pharmaceutical compositions containing mupirocin
09/23/2008CA2351727C Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione
09/23/2008CA2350942C Iron-containing protein composition
09/23/2008CA2338256C Bioenhanced formulations comprising eprosartan in oral solid dosage form
09/23/2008CA2337825C Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions
09/23/2008CA2336833C Remedy with antidepressant effects
09/23/2008CA2335393C Liposomal encapsulated nucleic acid-complexes
09/23/2008CA2335383C Protective coating for tablet
09/23/2008CA2333323C Method and compositions for treatment of cancers
09/23/2008CA2331264C Compositions and methods for drug delivery
09/23/2008CA2326222C Medicinal compositions
09/23/2008CA2318446C Sustained-release preparation for aii antagonist, production and use thereof
09/23/2008CA2310055C New urethanes, the thio and dithio analogues thereof,the salts thereof, pharmaceutical compositions containing these compounds and their use as well as process for preparing them
09/23/2008CA2305790C Styryl sulfone anticancer agents
09/23/2008CA2305183C Postsurgical treatment with dichloroacetate
09/23/2008CA2296739C Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
09/23/2008CA2293373C Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
09/23/2008CA2283643C Certain cyclic thio substituted acylaminoacid amide derivatives
09/23/2008CA2266479C Vitamin d analogues
09/23/2008CA2259179C Emulsion formulations for hydrophilic active agents
09/23/2008CA2258926C Methods for eliminating parasites and in particular ectoparasites of vertebrates, particularly of mammals and compositions for implementing these methods
09/23/2008CA2256751C Coated trimebutine maleate tablet
09/23/2008CA2208484C Soluble 2-chloro-2'-deoxyadenosine formulations
09/23/2008CA2198238C Piperidine derivatives as neurokinin antagonists
09/23/2008CA2163256C Adenoviral vectors of animal origin and use thereof in gene therapy
09/23/2008CA2147302C A lipid composition for normalizing injury
09/23/2008CA2139430C Polypeptides having serotoninergie activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof
09/23/2008CA2118373C Method to reverse the phenotype of transformed cells by the transcription factor irf-1
09/21/2008WO2009136903A1 Stable ophthalmical composition comprising ketotifen and naphazoline and methods of making same
09/21/2008CA2676401A1 Stable pharmaceutical compositions and methods of making and using same
09/20/2008CA2625381A1 Compositions containing retinoid and beta-aminoisobutyic acid derivatives
09/18/2008WO2008113078A1 Oncolytic vaccinia virus cancer therapy
09/18/2008WO2008113072A2 Gpcr enhanced neuroprotection to treat brain injury
09/18/2008WO2008113051A2 System for treating addictions
09/18/2008WO2008113043A1 Device and method for intraocular drug delivery
09/18/2008WO2008113006A1 Methods of using quinolinone compounds in treating sodium channel-mediated diseases or conditions
09/18/2008WO2008113003A1 Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and methods of using the same
09/18/2008WO2008113000A1 Anti-diabetic combinations comprising a slow release biguanide composition and an immediate release dipeptidyl peptidase iv inhibitor composition
09/18/2008WO2008112941A1 Composition and method for the treatment of diseases affected by a peptide receptor
09/18/2008WO2008112934A1 Intravesical apaziquone administration following transurethral resection for treating cancer
09/18/2008WO2008112900A1 Dibenzo[b,f][1,4]oxazapine compounds
09/18/2008WO2008112887A1 Methods of treating juvenile type 1 diabetes mellitus
09/18/2008WO2008112863A1 Compounds for the treatment of hepatitis c
09/18/2008WO2008112851A1 Cyclopropyl fused indolobenzazepine hcv inhibitors
09/18/2008WO2008112848A1 Compounds for the treatment of hepatitis c
09/18/2008WO2008112841A1 Compounds for the treatment of hepatitis c
09/18/2008WO2008112824A2 Oral zinc medicants useful for safely lowering free copper absorption and free copper levels
09/18/2008WO2008112799A1 Laulimalide and laulimalide analogs
09/18/2008WO2008112775A1 Compositions and kits for treating influenza
09/18/2008WO2008112772A2 Gene expression in peripheral blood mononuclear cells from children with diabetes
09/18/2008WO2008112734A1 Heterocyclic-carbonyl-diazabicycloalkanes as modulators of the neuronal nicotinic acetylcholine alpha 4 beta 2, subtype receptor for the treatment of cns related disorders
09/18/2008WO2008112722A2 Imatinib mesylate
09/18/2008WO2008112715A2 Novel agents of calcium ion channel modulators
09/18/2008WO2008112674A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/18/2008WO2008112659A2 Regulation of osteopontin
09/18/2008WO2008112657A1 Ferrate(vi)-containing compositions and methods of using ferrate(vi)
09/18/2008WO2008112647A2 Nitroxide radical as a treatment for neurodegeneration
09/18/2008WO2008112646A1 Aminopyridines useful as inhibitors of protein kinases
09/18/2008WO2008112642A1 Aminopyrimidines useful as inhibitors of protein kinases
09/18/2008WO2008112641A2 Methods and compositions for treating thalamocortical dysrhythmia
09/18/2008WO2008112562A1 Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia
09/18/2008WO2008112509A1 Treatment of melanoma
09/18/2008WO2008112498A2 Synthesis and characterization of polymorph form ii of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile
09/18/2008WO2008112495A1 Synthesis and characterization of polymorph form iii of 4-(2,(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile
09/18/2008WO2008112479A1 Salts of 3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-i-yl) -quinazolin-4-yl] -pyrrole-2, 5-di one
09/18/2008WO2008112473A1 Compounds for the treatment of hepatitis c
09/18/2008WO2008112440A1 Piperazine and piperidine mglur5 potentiators
09/18/2008WO2008112408A1 Spiro substituted compounds as angiogenesis inhibitors
09/18/2008WO2008112407A1 Spiro substituted compounds as angiogenesis inhibitors
09/18/2008WO2008112319A2 Methods of treating parkinson's disease using halogenated volatile compounds
09/18/2008WO2008112313A2 Processes for preparing solid states of o-desmethylvenlafaxine succinate
09/18/2008WO2008112251A1 Cyclopropyl-containing polyamine analogs as disease therapies
09/18/2008WO2008112246A2 Methods and compositions for identifying undifferentiated stem cells
09/18/2008WO2008112241A1 Methods an compositions for treatment of an interstitial lung disease
09/18/2008WO2008112238A1 2, 8-dimethyl-5- [2- (6-methylpyridin-3-yl) -ethyl] -2,3,4, 5-tetrahydro- ih- pyrido [4, 3 -b] indole dihydrochloride (dimebon) for the treatment of chronic pain
09/18/2008WO2008112227A1 Treatment with nicorandil and omega-3 fatty acids, and a combination product thereof
09/18/2008WO2008112217A1 Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1
09/18/2008WO2008112205A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
09/18/2008WO2008112199A1 Method for inhibiting topoisomerase ii
09/18/2008WO2008112195A1 Methods for identifying agents and their use for the prevention or stabilization of fibrosis
09/18/2008WO2008112167A1 Combination of metformin r-(+) lipoate and antihypertensive agents for the treatment of diabetic hyperglycemia and diabetic complications
09/18/2008WO2008112164A2 Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
09/18/2008WO2008112159A2 Monocyclic anilide spirolactam cgrp receptor antagonists
09/18/2008WO2008112156A1 Chemokine receptor modulators
09/18/2008WO2008112146A2 2d partially parallel imaging with k-space surrounding neighbors based data reconstruction
09/18/2008WO2008112144A1 Modulation of drug sensitivity
09/18/2008WO2008112141A1 Compositions for improving cellular uptake of a chemotherapeutic agent in a cell exhibiting mucin deregulation
09/18/2008WO2008112133A2 Pyridlyamidohafnium catalyst precursors, active species from this and uses thereof to polymerize alkenes
09/18/2008WO2008112124A2 Orally administrable films
09/18/2008WO2008112119A1 Use of modafinil to treat spasticity
09/18/2008WO2008112022A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
09/18/2008WO2008111978A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
09/18/2008WO2008111956A2 Fatty acid oxidation inhibitors treating hyperglycemia and related disorders
09/18/2008WO2008111919A2 A novel combination of water-soluble forms of coenzyme q10 and l-carnitine, process of production and use
09/18/2008WO2008111916A1 Glycosphingolipid-aided intracellular delivery of cargo molecules
09/18/2008WO2008111908A1 Five- and six-membered conformationally locked 2',4'- carbocyclic ribo-thymidines for the treatment of infections and cancer
1 ... 3077 3078 3079 3080 3081 3082 3083 3084 3085 3086 3087 3088 3089 3090 3091 3092 3093 3094 3095 3096 3097 ... 7860